Prolonging survival, achieving symptoms palliation and preserving quality of life are the primary therapeutic goals of treatments administered after disease progression in mCRC. Even if the impact of these therapies on the prognosis of affected patients is less relevant than the impact of the upfront treatment, tailoring the optimal second-line therapy is increasingly important. Several therapeutic options are available, and different factors including not only patient- and disease-related characteristics, but also the first-line treatment received (i.e., type, timing of disease progression, observed outcome and reported toxicities) may drive this choice. Herein, we describe the current state of the art in the landscape of treatments after progression in mCRC. Based on a critical review of the literature, we built a patient-oriented therapeutic algorithm, aiming to guide clinicians in their daily decision-making.
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm / Antoniotti C.; Moretto R.; Rossini D.; Masi G.; Falcone A.; Cremolini C.. - In: CANCER TREATMENT REVIEWS. - ISSN 0305-7372. - ELETTRONICO. - 92:(2021), pp. 102135.0-102135.0. [10.1016/j.ctrv.2020.102135]
Treatments after first progression in metastatic colorectal cancer. A literature review and evidence-based algorithm
Rossini D.;
2021
Abstract
Prolonging survival, achieving symptoms palliation and preserving quality of life are the primary therapeutic goals of treatments administered after disease progression in mCRC. Even if the impact of these therapies on the prognosis of affected patients is less relevant than the impact of the upfront treatment, tailoring the optimal second-line therapy is increasingly important. Several therapeutic options are available, and different factors including not only patient- and disease-related characteristics, but also the first-line treatment received (i.e., type, timing of disease progression, observed outcome and reported toxicities) may drive this choice. Herein, we describe the current state of the art in the landscape of treatments after progression in mCRC. Based on a critical review of the literature, we built a patient-oriented therapeutic algorithm, aiming to guide clinicians in their daily decision-making.I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.